KYTHERA BIOPHARMACEUTICALS INC Research and Development Expense
KYTHERA BIOPHARMACEUTICALS INC reported Research and Development Expense of $11.23 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-08-06
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2015-06-30 was $11.23M, a 2.42% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2015-03-31 was $15.27M, a 52.97% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2014-12-31 was $13.50M, a 46.64% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2014-09-30 was $13.40M, a 92.27% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for fiscal 2014 was $47.84M, a 40.81% increase from fiscal 2013.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for fiscal 2013 was $33.97M, a 21.33% decline from fiscal 2012.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for fiscal 2012 was $43.18M, a 173.91% increase from fiscal 2011.
- KYTHERA BIOPHARMACEUTICALS INC research and development expense for fiscal 2011 was $15.77M, a 6.23% increase from fiscal 2010.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2015-06-30 | $11.23M 10-Q · filed 2015-08-06 | $26.49M 10-Q · filed 2015-08-06 | $39.99M derived: sum of 3 quarters · filed 2015-08-06 | $53.39M derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | $15.27M 10-Q · filed 2015-05-07 | $28.76M derived: sum of 2 quarters · filed 2015-05-07 | $42.16M derived: sum of 3 quarters · filed 2015-05-07 | $53.13M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $26.90M derived: sum of 2 quarters · filed 2015-03-02 | $37.86M derived: sum of 3 quarters · filed 2015-08-06 | $47.84M 10-K · filed 2015-03-02 |
| 2014-09-30 | $13.40M 10-Q · filed 2014-11-10 | $24.36M derived: sum of 2 quarters · filed 2015-08-06 | $34.34M 10-Q · filed 2014-11-10 | $43.55M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-06-30 | $10.96M 10-Q · filed 2015-08-06 | $20.94M 10-Q · filed 2015-08-06 | $30.15M derived: sum of 3 quarters · filed 2015-08-06 | $37.12M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $9.98M 10-Q · filed 2015-05-07 | $19.18M derived: sum of 2 quarters · filed 2015-05-07 | $26.15M derived: sum of 3 quarters · filed 2015-05-07 | $33.92M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $16.17M derived: sum of 2 quarters · filed 2015-03-02 | $23.94M derived: sum of 3 quarters · filed 2015-03-02 | $33.97M 10-K · filed 2015-03-02 |
| 2013-09-30 | $6.97M 10-Q · filed 2014-11-10 | $14.74M derived: sum of 2 quarters · filed 2014-11-10 | $24.77M 10-Q · filed 2014-11-10 | $39.15M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $7.77M 10-Q · filed 2014-08-07 | $17.80M 10-Q · filed 2014-08-07 | $32.18M derived: sum of 3 quarters · filed 2015-03-02 | $46.10M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $10.03M 10-Q · filed 2014-05-08 | $24.41M derived: sum of 2 quarters · filed 2015-03-02 | $38.33M derived: sum of 3 quarters · filed 2015-03-02 | $46.73M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $14.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $28.30M derived: sum of 2 quarters · filed 2015-03-02 | $36.70M derived: sum of 3 quarters · filed 2015-03-02 | $43.18M 10-K · filed 2015-03-02 |
| 2012-09-30 | $13.92M 10-Q · filed 2013-11-14 | $22.32M derived: sum of 2 quarters · filed 2013-11-14 | $28.81M 10-Q · filed 2013-11-14 | $34.98M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $8.40M 10-Q/A · filed 2013-09-27 | $14.88M 10-Q/A · filed 2013-09-27 | $21.06M derived: sum of 3 quarters · filed 2014-03-17 | $24.30M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $6.49M 10-Q/A · filed 2013-09-27 | $12.66M derived: sum of 2 quarters · filed 2014-03-17 | $15.90M derived: sum of 3 quarters · filed 2014-03-17 | |
| 2011-12-31 | $6.17M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | $9.41M derived: sum of 2 quarters · filed 2014-03-17 | $15.77M 10-K · filed 2014-03-17 | |
| 2011-09-30 | $3.24M 10-Q/A · filed 2012-12-03 | $9.59M 10-Q/A · filed 2012-12-03 | ||
| 2010-12-31 | $14.84M 10-K/A · filed 2013-09-27 |